Day: 9 July 2021


Senseutics (t/a Vatic) secures £4.6 million Seed investment led by

Vatic raises £4.6m to deliver a new proactive form of healthcare with at-home tests, starting with COVID-19 Vatic has developed patented technology which identifies infectious viruses by mimicking the surface of a human cell – a fundamental redesign of existing lateral flow test technology to create its own class of infectiousness test. Vatic’s first product […]Read More

Series A

MiNA Therapeutics secures £10.83 million Series A Follow On investment

LONDON, United Kingdom, 6 July 2021 — MiNA Therapeutics Limited (“MiNA” or the “Company”), the pioneer in small activating RNA therapeutics, announces that Eli Lilly and Company has entered into a definitive agreement under which it will make a direct equity investment in MiNA. The equity investment of approximately $15m follows the recent agreement between […]Read More